首页|Centre Hospitalo-Universitaire de Toulouse Reports Findings in Artificial Intelligence (Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study)
Centre Hospitalo-Universitaire de Toulouse Reports Findings in Artificial Intelligence (Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Artificial Intelligence is the subject of a report. According to newsreporting originating in Toulouse, France, by NewsRx journalists, research stated, “We designed artificialintelligence-based prediction models (AIPM) using 52 diagnostic variables from 3687 patients included inthe DATAML registry treated with intensive chemotherapy (IC, N = 3030) or azacitidine (AZA, N = 657)for an acute myeloid leukemia (AML). A neural network called multilayer perceptron (MLP) achieved aprediction accuracy for overall survival (OS) of 68.5% and 62.1% in the IC and AZA cohorts, respectively.”
ToulouseFranceEuropeAcute Myeloid LeukemiaArtificial IntelligenceCancerEmerging TechnologiesHealth and MedicineHematologyLeukemiaMachine LearningMyeloid LeukemiaOncologyRisk and Prevention
NETL
NSTL
